Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 5 of 5 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Orelabrutinib | 1件: Orelabrutinib Orelabrutinib (Orelabrutinib) | 1件: Orelabrutinib
Orelabrutinib
(Orelabrutinib) 💬1. Orelabrutinib
| 1件: BTK BTK 💬1. Orelabrutinib
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway ... | 4件: 13 13, 49, 61, 63 💬
| ||||||||||||||
| 2 | Orelabrutinib (High Dose) | 1件: Orelabrutinib Orelabrutinib (Orelabrutinib) | 1件: Orelabrutinib
Orelabrutinib
(Orelabrutinib) 💬2. Orelabrutinib (High Dose)
| 1件: BTK BTK 💬2. Orelabrutinib (High Dose)
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway ... | 1件: 49 49 💬2. Orelabrutinib (High Dose)
| ||||||||||||||
| 3 | Orelabrutinib (Low Dose) | 1件: Orelabrutinib Orelabrutinib (Orelabrutinib) | 1件: Orelabrutinib
Orelabrutinib
(Orelabrutinib) 💬3. Orelabrutinib (Low Dose)
| 1件: BTK BTK 💬3. Orelabrutinib (Low Dose)
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway ... | 1件: 49 49 💬3. Orelabrutinib (Low Dose)
| ||||||||||||||
| 4 | Orelabrutinib( higher dose) | 1件: Orelabrutinib Orelabrutinib (Orelabrutinib) | 1件: Orelabrutinib
Orelabrutinib
(Orelabrutinib) 💬4. Orelabrutinib( higher dose)
| 1件: BTK BTK 💬4. Orelabrutinib( higher dose)
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway ... | 1件: 63 63 💬4. Orelabrutinib( higher dose)
| ||||||||||||||
| 5 | Orelabrutinib( lower dose) | 1件: Orelabrutinib Orelabrutinib (Orelabrutinib) | 1件: Orelabrutinib
Orelabrutinib
(Orelabrutinib) 💬5. Orelabrutinib( lower dose)
| 1件: BTK BTK 💬5. Orelabrutinib( lower dose)
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway ... | 1件: 63 63 💬5. Orelabrutinib( lower dose)
|